Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners
MWN-AI** Summary
Albemarle Corporation (NYSE: ALB), a leading global provider of essential elements across various sectors, has finalized the sale of a controlling interest in Ketjen Corporation's refining catalyst solutions business to KPS Capital Partners, LP. This strategic move allows Albemarle to maintain a minority interest in Ketjen while granting KPS majority control, including a dominant position on the Board of Directors. Notably, Albemarle retains full ownership of Ketjen's Performance Catalyst Solutions business, which has been seamlessly integrated into its broader portfolio.
This transaction, along with the recent sale of Albemarle's 50% stake in the Eurecat joint venture to Axens SA, has generated approximately $670 million in pre-tax proceeds. The company plans to leverage these funds for debt reduction and other corporate initiatives, underscoring its commitment to financial health and operational flexibility. Kent Masters, Albemarle's Chairman and CEO, expressed confidence in Ketjen's growth trajectory, indicating that this investment reflects a strong belief in the company's long-term value creation potential.
Goldman Sachs & Co. LLC acted as the exclusive financial advisor for Albemarle, while K&L Gates LLP provided legal counsel during the transaction. KPS Capital Partners, known for its focus on restructuring industrial and manufacturing companies, aims to enhance the strategic position and profitability of its portfolio, which currently encompasses numerous global manufacturing facilities.
Albemarle, revered for its innovative approaches, continues to engage in partnerships and investments that facilitate advancements in mobility, energy solutions, and health sectors. This transaction not only strengthens Albemarle's operational posture but also positions it strategically for future growth within competitive markets.
MWN-AI** Analysis
Albemarle Corporation’s recent completion of the sale of a controlling stake in Ketjen Corporation to KPS Capital Partners represents a significant strategic move that investors should scrutinize closely. The transaction, which fetched approximately $670 million in pre-tax proceeds, is poised to enhance Albemarle’s financial flexibility and focus on its core business segments.
Retaining a minority stake in Ketjen while divesting operational control highlights Albemarle's commitment to strategic partnerships—even as it refines its investment portfolio. This divestiture follows the company’s earlier sale of its interest in the Eurecat joint venture, further consolidating Albemarle's efforts to streamline operations and reduce debt.
Investors should view this transaction as an indication of Albemarle's proactive management approach and its intent to leverage proceeds for debt reduction and general capital purposes. Such a strategy is favorable in the current economic climate, where maintaining balance sheet strength is paramount. KPS’s involvement is particularly noteworthy, given their history of enhancing operational efficiency and profitability in their portfolio companies. Investors may find that this partnership will enhance Ketjen's growth prospects, while also providing Albemarle with ongoing strategic benefits.
Albemarle’s focus on critical resources for mobility and energy solutions continues to position it favorably in industries poised for growth. However, investors must remain mindful of potential risks outlined in its forward-looking statements, including macroeconomic factors and changes in market demands.
In conclusion, current Albemarle stakeholders and potential investors should monitor the effectiveness of this strategic shift. The consolidation not only signals Albemarle’s commitment to its core capabilities but also its strategic intent to enhance shareholder value through improved financial and operational efficiencies. As always, investors should consider these developments against the backdrop of broader market conditions and perform due diligence before making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced it has completed the sale of a controlling stake in Ketjen Corporation's refining catalyst solutions business (Ketjen) to affiliates of KPS Capital Partners, LP (KPS).
Albemarle retains a minority stake in Ketjen, with KPS having a majority of the Board of Directors and operational control. Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business, which has been integrated into Albemarle's product portfolio.
Combined with the sale of its 50% interest in the Eurecat joint venture to Axens SA, which was completed in January 2026, Albemarle has received a combined $670 million in pre-tax proceeds between the two transactions. Albemarle expects to use the proceeds for debt reduction and other general corporate purposes.
"Our continued investment in Ketjen alongside KPS demonstrates our confidence in the company's growth and value-creation potential," said Kent Masters, Chairman and CEO of Albemarle. "We are committed to supporting Ketjen's next chapter while strengthening Albemarle's portfolio focus and financial flexibility."
Goldman Sachs & Co. LLC acted as exclusive financial advisor, and K&L Gates LLP served as legal advisor to Albemarle for the transaction.
About Albemarle
Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.
Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.
About KPS Capital Partners
KPS, through its affiliated management entities, is the manager of the KPS Special Situations Funds, a family of investment funds with approximately $19.5 billion of assets under management (as of September 30, 2025). For over three decades, the Partners of KPS have worked exclusively to realize significant capital appreciation by making controlling equity investments in manufacturing and industrial companies across a diverse array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing. KPS creates value for its investors by working constructively with talented management teams to make businesses better, and generates investment returns by structurally improving the strategic position, competitiveness and profitability of its portfolio companies, rather than primarily relying on financial leverage. The KPS Funds' portfolio companies currently generate aggregate annual revenues of approximately $21.2 billion, operate 202 manufacturing facilities in 21 countries, and have approximately 55,000 employees, directly and through joint ventures worldwide (as of September 30, 2025). The KPS investment strategy and portfolio companies are described in detail at www.kpsfund.com.
Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition" "anticipate," "believe," "estimate," "expect," "goals" "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will" and similar references to future periods. Forward-looking statements may include statements regarding: plans and expectations regarding use of transaction proceeds, financial flexibility and optionality, future investments and support, value-creation potential, portfolio focus, other underlying assumptions and outlook considerations, and all other information relating to matters that are not historical facts. These and other forward-looking statements are based on management's current estimates, assumptions and expectations and involve risks and uncertainties that could significantly affect expected results. Actual results could differ materially from those expressed or implied in the forward-looking statements if one or more of the underlying estimates, assumptions or expectations prove to be inaccurate or are unrealized. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: breaches of contract; changes in economic and business conditions; changes in trade policies and tariffs; technological change and development; completion of the audit of our annual financial statements; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; geopolitical conflicts and political unrest; trade policies and tariffs; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
Investor Relations Contact: +1 (980) 308-6194, invest@albemarle.com
Media Contact: Ryan Dean, +1 (980) 308-6310, media@albemarle.com
SOURCE Albemarle Corporation
FAQ**
How does the completion of the sale of a controlling stake in Ketjen to KPS Capital Partners affect Albemarle Corporation ALB's overall business strategy and financial performance?
What are the anticipated uses of the $670 million in pre-tax proceeds from the sale of Ketjen and the Eurecat joint venture by Albemarle Corporation ALB?
What role will Albemarle Corporation ALB play in Ketjen’s future growth and operations with its retained minority stake and performance catalyst solutions business?
How does the partnership with KPS Capital Partners align with Albemarle Corporation ALB’s long-term goals in the refining catalyst solutions market?
**MWN-AI FAQ is based on asking OpenAI questions about Albemarle Corporation (NYSE: ALB).
NASDAQ: ALB
ALB Trading
0.84% G/L:
$163.50 Last:
1,155,230 Volume:
$158.62 Open:
